Susceptibility tests with aminoglycosides against Staphylococcus aureus have revealed discrepancies between the minimal inhibitory concentrations and the minimal bactericidal concentrations. To further evaluate these discrepancies, kill curves were perforned against a susceptible strain of S. -aureus with five different aminoglycosides (amikacin, kanamycin, tobramycin, gentamicin, sisomicin) at concentrations up to 16-fold above the minimal inhibitory concentration. Results revealed the presence of small subpopulations of cells capable of growth within 24 h in concentrations of aminoglycoside up to eightfold above the minimal inhibitory concentration for the parent strain. These subpopulations occurred at a frequency of -10-7 parent cells, were not physiologically different from the susceptible parent strains, and were present in approximately one-half of 30 strains of S. aureus tested. The resistance of these subpopulations was approximately eightfold higher than that of the parent for all five aminoglycosides and was independent of concentration or type of aminoglycoside used to select them. This resistance was not due to extracellular degradation ofdrug and was stable over eight transfers in drug-free medium, except when selected by gentamicin or sisomicin.
Susceptibility tests with aminoglycosides against Staphylococcus aureus have revealed discrepancies between the minimal inhibitory concentrations and the minimal bactericidal concentrations. To further evaluate these discrepancies, kill curves were perforned against a susceptible strain of S. -aureus with five different aminoglycosides (amikacin, kanamycin, tobramycin, gentamicin, sisomicin) at concentrations up to 16-fold above the minimal inhibitory concentration. Results revealed the presence of small subpopulations of cells capable of growth within 24 h in concentrations of aminoglycoside up to eightfold above the minimal inhibitory concentration for the parent strain. These subpopulations occurred at a frequency of -10-7 parent cells, were not physiologically different from the susceptible parent strains, and were present in approximately one-half of 30 strains of S. aureus tested. The resistance of these subpopulations was approximately eightfold higher than that of the parent for all five aminoglycosides and was independent of concentration or type of aminoglycoside used to select them. This resistance was not due to extracellular degradation ofdrug and was stable over eight transfers in drug-free medium, except when selected by gentamicin or sisomicin.
Studies concerning the effects of procedural variations on the activity of aminoglycosides have revealed that a single procedural change can significantly alter results, particularly in tests with Staphylcoccus aureus (14) . Variations in such factors as inoculum and type of medium used may at times also alter the clinical interpretation of results, and significant discrepancies between the minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) ofaminoglycosides have been observed (5, 9, 12, 16) . These observations suggest the presence of a small subpopulation of cells within the susceptible parent strain which are more resistant to the effects of the aminoglycoside. Therefore, the purpose of this study was to (i) evaluate the bactericidal activity of aminoglycosides against S. aureus by the use of kill curves, (ii) characterize the more resistant cells selected from strains of S.
aureus which appeared to be susceptible to aminoglycosides by MIC determinations, and (iii) determine the prevalence of strains containing these more resistant cells. ,ug/ml were prepared in sterile distilled water (weight corrected for potency) and then sterilized by membrane filtration (pore size, 0.45-,&m; Millipore Corp., Bedford, Mass.). Appropriate dilutions were made in sterile Mueller-Hinton broth (MHB; Baltimore Biological Laboratories) to yield 100 ,ug of each drug per ml.
Broth dilution susceptibility tests. Serial twofold tube dilution tests were performed in MHB in a volume of 3 ml per tube. Dilutions of an 18-h broth culture were made to produce a final bacterial population in each tube of 104 to 5 x 104 colony-forming units (CFU) per ml. MIC was defined as the lowest concentration of drug that prevented macroscopic growth after incubation for 18 to 24 h at 37°C. MBCs were determined by subculturing 0.01 ml (calibrated loop) from each clear tube onto a blood agar plate. The MBC was defined as the lowest concentration of drug that prevented all growth on subculture. Dilution susceptibility tests were performed simultaneously with all five aminoglycosides against each strain. All subsequent references to MICs or MBCs, unless otherwise stated, pertain to results derived from broth dilution susceptibility tests. Since stationary-phase cells were used in these assays, all further studies were also performed with stationaryphase cells for consistency.
Kill curves. Flasks containing aminoglycoside in MHB were inoculated with an appropriate dilution of an 18-h culture of S. aureus to produce a final bacterial population of approximately 105 CFU/ml. Samples were removed at 0, 0.5, 1, 2, 4, 6, 8, 24, and 48 h of incubation, and the number of viable cell units was counted using a standard agar dilution, pour-plate technique in Mueller-Hinton agar (MHA). Colony counts were based on counts on duplicate plates. Kill curves were performed on each strain simultaneously with all five aminoglycosides.
Antibiotic inactivation tests. MHB containing aminoglycoside was inoculated with approximately 105 CFU/ml and incubated for 24 h at 37°C. All bacteria were removed by membrane filtration (Millipore Corp.). Arithmetic dilutions of the filtrates were made, and 0.02 ml of each was added to a sterile 7-mm paper disk. These disks were then tested for activity against a laboratory stock strain ofS. aureus using the procedure described by Bauer and associates (1) Stability of resistance. Each strain was subcultured daily on drug-free blood agar plates. The susceptibility of each subculture to all five aminoglycosides was determined simultaneously by an agar dilution procedure. Organisms (approximately 5 x 104 CFU) were placed onto the surface of each plate with a multiple inoculator device (15) . The MIC was defined as the lowest concentration of drug inhibiting all growth after incubation for 24 h at 37°C in air.
RESULTS
Kinetics of the bactericidal activity of aminoglcyosides against S. aureus. To more closely examine the discrepancies seen between the MICs and MBCs of aminoglycosides for S. aureus, the kinetics of bactericidal activity were studied by the use of kill curves. Various concentrations of each aminoglycoside above the MIC were used in these tests. As shown in Fig. 1 that were capable of growing in concentrations of aminoglycoside above the MIC (superinhibitory concentrations) was detennined in agar tests ( Table 1 ). The frequencies of cells capable of growing in drug-containing agar decreased progressively one log per twofold increase in amikacin, kanamycin, and tobramycin. At eightfold above the MIC for the parent strain (8-MICp), the frequency was 10-7 or greater.
The frequency of cells capable of growing in gentamicin dropped two logs between two-and fourfold above the MIC, but was also 10-7 at 8-MICp. For sisomicin, the frequency dropped one log per twofold increase in concentration, but the frequency at 8-MICp was less than 10-7.
The growth observed in the kill curves after 7 h in superinhibitory amounts of aminoglycoside suggested the presence of a more resistant cell population. Therefore, the cells recovered at 24 h were tested for their susceptibility to the aminoglycoside which had been used in the kill curve and compared to that of the parent strain ( Table 2) . For each aminoglycoside, the increase in MIC for these cells above that for the parent strain was similar regardless of the concentration used in the kill curve. Furthermore, every increase observed was fourfold or greater. The increase in MBCs for these cells above that for the parent strain showed no consistent pattern like that seen for the MICs Since the R8 cells selected with amikacin had large discrepancies between MICs and MBCs, tests were performed to determine if these R8 cells contained even more highly resistant cells. These R8 cells were placed in broth containing a concentration of amikacin eightfold above the MIC for the R8 cells. The cells that were recovered in 24 h were then tested for their susceptibility to all five aminoglycosides. The MIC of all five aminoglycosides for these cells was increased to the level of the MBC for the R8 cells, and the MBCs for these cells did not increase. Thus, the discrepancies between MICs and MBCs were eliminated.
Kill curves were repeated to compare the R8 cells to the parent strain relative to (i) bactericidal activity of aminoglycosides and (ii) their normal growth rates. A single concentration of 8-MICp was used in these tests. As shown in Fig. 3 , the viability ofthe parent strain dropped initially as before with amikacin, kanamycin, tobramycin, and gentamicin, with growth occurring after 7 h. No significant growth was observed in sisomicin between 7 and 24 h. In tests with the R8 cells, amikacin slowed the WILSON AND SANDERS growth rate of the R8 cells, but growth continued steadily until, at 24 h, it was equivalent to the two controls (Fig. 3A) . Kanamycin alo slowed the growth rate of the R8 cells to the extent that at 24 h the number of viable cells was one log lower than both controls (Fig. 3B) .
ANTIMICROB. AGENTS CHEMOTHER.
Tobramycin produced a bacteriostatic effect on the R8 cells, whereas both controls were equivalent (Fig. 3C) . Gentamicin produced little effect on the growth rate ofthe R8 cells; however, the growth rate of the R8 control was somewhat slower than that of the parent control (Fig. 3D) . Sisomicin produced a drop in the viable cell count of both parent and R8 cells, and no significant growth occurred after 7 h. The parent and R8 cell controls were equivalent (Fig. 3E) . The changes observed in the kill curves with the R8 cells further substantiated the presence of a subpopulation of more resistant cells within the parent strain.
Prevalence of R8 cells in clinical isolates of S. aureus. Concentrations ofaminoglycoside, 8- MICp, appeared to be the maximum concentration in broth for the selection of R8 cells. Therefore, 30 different clinical isolates of S. aureus were examined for the presence of R8 cells ( Table 4 ). Of 30 strains tested, the percentage of strains containing R8 cells was 73% for amikacin, 77% for kanamycin, 93% for tobramycin, 83% for gentamicin, and 87% for sisomicin.
These 30 strains were next screened for the presence of cells capable of growing in agar containing aminoglycoside at 8-MIC, and occurring at a frequency of 10-7 parent cells or more. The percentage of the 30 strains containing such cells was 53% for amikacin, 43% for kanamycin, 60% for tobramycin, 53% for gentamicin, and 47% for sisomicin. The percentage of the 30 strains that contained the more resistant cells in both the broth and agar tests was 43% for amikacin, 36% for kanamycin, 53% for tobramycin, 43% for gentamicin, and 40% for sisomicin. The limiting factor of this evaluation was the frequency of 10-7 since several of the strains demonstrated R8 cells in broth tests, but agar tests showed the more resistant cells occurred at a frequency less than 10-7. A resistant subpopulation was thus defined as cells within a parent strain ofS. aureus (i) occurring at a frequency of at least 1 in 107 parent cells and (ii) capable of growing in concentrations of aminoglycoside 8-MICp within 24 h.
Characterization of the resistance. The resistant subpopulations were characterized with regard to stability of resistance, extracellular degradation of drug, and physiological similarity to the parent strain. To determine the stability of this resistance, each subpopulation was transferred daily for 8 days in drug-free media and retested for its susceptibility to aminoglycosides. Those subpopulations selected by gentamicin and sisomicin reverted to the parent sensitivity to all five aminoglycosides after two transfers. The subpopulations selected by amikacin, kanamycin, and tobramycin maintained their resistance to all five aminoglycosides after eight transfers. Tests for bioactive drug were performed on cell-free filtrates made from 24-h subpopulation cultures, growing in concentrations of aminoglycoside 8-MIC,. The tests revealed that these filtrates contained as much active antibiotic as fresh drug and drug incubated in sterile broth. To determine their physiological similarity to the parent strain, resistant subpopulations were tested for the ability to ferment glucose, sucrose, mannitol, and lactose, and for the ability to produce coagulase and DNase. The tests revealed no physiological differences between the parent strain and subpopulations. DISCUSSION The results of this study indicated that the discrepancies observed between the MICs and MBCs of aminoglycosides against S. aureus were due to the presence of small subpopulations of cells more resistant to the bactericidal effects of aminoglycosides than the parent strain. These subpopulations were selected by a single exposure to superinhibitory concentrations of aminoglycoside. Kill curves performed with the subpopulations in concentrations of aminoglycoside 8-MICp shoWed no decreased viability (except with sisomicin), but did suggest some bacteriostatic effect, particularly with tobramycin. The drop in the viability of the sisomicin-selected subpopulations in sisomicin may have been due to reversion to parent strain susceptibility since sisomicin-selected subpopulations were unstable. The resistant subpopulations selected by each of the five aminoglycosides were physiologically similar to the parent strain, and those subpopulations selected by amikacin, kanamycin, and tobramycin were stable upon transfer to drug-free medium.
The resistant subpopulations that were selected with amikacin, kanamycin, and tobramycin in this study have somewhat different characteristics than the resistant cells described by Price et al. (12) and by Weinstein et al. (18) . In those studies the resistant cells were selected in vitro by multiple transfer in subinhibitory amounts of aminoglycoside. Although the cells showed cross-resistance to the other aminoglycosides, they reverted rapidly to susceptibility, grew more slowly than the parent strain, were nutritionally dependent, and lacked virulence. The results of this study are most similar to those described in studies with the penicillin, BL-P1654 and Pseudomonas (7, 14) . As in this study, large discrepancies had been observed between MICs and MBCs of BL-P1654 against Pseudomonas. Strains of Pseudomas were shown to contain small subpopulations of cells 4-to 32-fold more resistant to BL-P1654 than the parent Pseudomonas strain. Those subpopulations were selected by a single exposure to superinhibitory concentrations of drug and were stable upon transfer in drug-free media. The presence of those subpopulations explained the significant discrepancies observed between the MIC and MBC ofBL-P1654.
Determination of the precise mechanism of resistance of the subpopulations was beyond the scope of this study. However, physiological similarities of the subpopulations to the parent strain as demonstrated by growth curves in drug-free media and biochemical tests, and the cross-resistance to the other aminoglycosides, suggested the production of an inactivating enzyme. Since no extracellular inactivation ofthe aminoglycoside was observed, enzyme inactivation, if it is responsible for the resistance, must occur within or at the surface of the cell. The only known enzyme capable of inactivating all five ofthe aminoglycosides used in this study is kanamycin acetyltransferase, which has not been demonstrated in-S. aureus (2, 16, 20) . The frequency of these subpopulations (10-7 parent cells) is approximately that of spontaneous mutation which produces ribosomal resistance (8, 19) . However, ribosomal resistance usually confers a high level of resistance (MIC -250 ,ug/ ml), higher than that of the subpopulations, and it has not been demonstrated to confer cross-resistance to other aminoglycosides (4) . The only other known mechanism of resistance to aminoglycosides is cellular impermeability. This mechanism has been shown to be responsible for the cation-dependent resistance ofPseudomonas (21) and the intrinsic resistance of enterococci (11) to aminoglycosides. Although cellular impermeability to methicillin has been suggested in strains of methicillin-resistant S. aureus (3), impermeability to aminoglycosides has not been reported to date.
The presence of such subpopulations in a high percentage of clinical isolates ofS. aureus may be of clinical importance. The physiological similarity of the subpopulations to the parent strain suggests that they may also have equivalent pathogenic capabilities. Thus, they may be responsible for some ofthe staphylococcal complications observed during therapy with aminoglycosides. The most frequently observed complication is that of staphylococcal superinfection during aminoglycoside therapy for gram-negative infections (6, 10) . In certain instances, these superinfections may arise from in vivo selection of resistant subpopulations since the concentration of aminoglycoside required to kill the subpopulations in vitro were at or above levels that can be achieved with safety in man. Similar studies with staphylococci isolated from patients with superinfections should be performed to directly determine the role of such subpopulations in this complication of aminoglycoside therapy.
